Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized versus Intravenous Fentanyl for Dyspnea Relief in Terminally Ill Patients in the Emergency Department
TCTR20260104005Phase 3Recruiting
- Sponsor
- Mahidol University
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in Dyspnoea (SOB), sponsored by Mahidol University. Started Jul 2025; status: recruiting.
02
Drugs
fentanyl
03
Conditions
Dyspnoea (SOB)
Beyond the preview
Go deeper on TCTR20260104005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260104005.